IOBT Projected Dividend Yield
IO Biotech Inc ( NASDAQ : IOBT )IO Biotech is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on its T-win technology platform. Co.'s product candidates are designed to induce the immune system to simultaneously target and disrupt various pathways that regulate tumor-induced immunosuppression. Co.'s main product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. In addition to IO102, IO103 and IO112, Co. is evaluating additional candidates that have potential for use in solid tumors. 20 YEAR PERFORMANCE RESULTS |
IOBT Dividend History Detail IOBT Dividend News IOBT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |